Calcium Trisodium Pentetate (Ca-DTPA) ampoules

Organization

Department of National Defence (DND)

Closes

November 25, 2026 at 2:00 p.m.

Category

goods

Notice type

Advance Contract Award Notice

Delivery

Canada

Estimated value

Not stated

Reference

W6369-27-A062

Trade agreements

Canadian Free Trade Agreement (CFTA)

Closing time as published by the source; time zone assumed: America/Toronto.

NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND), through the Strategic Medical Countermeasures Program (SMCP) on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), has a requirement for the supply of Calcium Trisodium Pentetate (Ca-DTPA) ampoules for the treatment of Canadian Armed Forces (CAF) personnel who may have been exposed to radioactive contamination involving transuranic elements. The Ca-DTPA product must consist of sterile Calcium Trisodium Pentetate solution for injection, containing approximately 1,000 mg to 1,055 mg of active ingredient in a 5 mL ampoule suitable for intravenous administration. The product is intended for use as a medical countermeasure to enhance the elimination of internally deposited radioactive transuranic elements, including plutonium, americium and curium, following confirmed or suspected radiological exposure. The product must meet all applicable regulatory, quality assurance, packaging, labelling and shelf-life requirements specified in the solicitation documents. The initial requirement consists of the supply of 250 Ca-DTPA ampoules for delivery no later than 1 March 2027. The resulting contract is anticipated to be valid from contract award date to 31 March 2031 and includes additional scheduled deliveries of 250 ampoules in Fiscal Year 2027-2028 and 250 ampoules in Fiscal Year 2028-2029. The contract will also include an option for up to an additional 500 ampoules exercisable during the contract period. This procurement will be conducted through an Advance Contract Award Notice (ACAN). The Government of Canada has identified Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG as the only supplier currently known to satisfy the operational, clinical and technical requirements associated with this requirement. Suppliers that consider themselves fully qualified and capable of meeting the complete requirement may submit a Statement of Capabilities during the posting period. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Barring any applicable trade agreement exceptions or other legal restrictions, eligible suppliers may participate in this solicitation process. NOTE TO SUPPLIERS: Procurement Assistance Canada offers seminars to businesses interested in learning how to sell goods and services to the Government of Canada. These seminars are provided free of charge.

Source

CanadaBuys (Government of Canada) · Open Government Licence – Canada

View the original notice ↗

Notice details come from the public source named here; 3ENET republishes them under the source licence and links to the original, which is authoritative.

Last updated: November 12, 2026 at 1:15 a.m.

Find out if this tender fits you

Create a free 3ENET account to save it, see why it matches your capabilities, and find people to bid with.